What does DR. MARC FOL do?

DR. MARC FOL is a specialist medical practice in Londerzeel. Private Limited, started on 18 February 2003, 1 establishment.

What is the address of DR. MARC FOL?

The registered office of DR. MARC FOL is located at Maldersesteenweg 37, 1840 Londerzeel.

Is DR. MARC FOL still active?

Yes. According to the CBE (31 October 2026) DR. MARC FOL is active, legal situation “Normale toestand”, started on 18 February 2003.

Is DR. MARC FOL registered on Peppol?

Yes, DR. MARC FOL is registered on the Peppol network with ID 0208:0479575324.

What is the enterprise number of DR. MARC FOL?

The enterprise number of DR. MARC FOL is BE0479575324.

When was DR. MARC FOL founded?

DR. MARC FOL was founded on 18 February 2003.

Who are the directors of DR. MARC FOL?

According to the 2025 annual accounts, the directors of DR. MARC FOL are: Marc Fol.

Is DR. MARC FOL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MARC FOL make in 2025?

DR. MARC FOL recorded a loss after taxes of € 101,559 in financial year 2025.

What is the revenue of DR. MARC FOL?

As a small company, DR. MARC FOL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -84,821.

DR. MARC FOL (Private Limited) - Londerzeel

Dossier DR. MARC FOL, printed on 1 November 2026 from databakkes.be/en/0479575324/dr-marc-fol. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MARC FOL from Londerzeel, company number BE0479575324, closed financial year 2025 with a result of € -101,559 after tax. For that financial year DR. MARC FOL recorded a gross margin of € -84,821 and equity of € 2.3 million. Compared with financial year 2024, the result moved from € 845,297 to € -101,559. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 12, 2026.

What it is worth Healthy

€ 2.3 million

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -101,559

▼ still € 845,297 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 226,788

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 2.3 million.

People and assets in 2025

Wage cost

€ 6,431

▲ € 6,025 vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 160

▼ 76% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 332

▲ € 313 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,100

▼ 97% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 213,473 Gross margin 2022: € 213,473 First fiscal year in the series	€ 273,832 Gross margin 2023: € 273,832 ▲ 28% vs 2022 (€ 213,473) Favourable step	€ 1,245,286 Gross margin 2024: € 1,245,286 ▲ € 971,454 vs 2023 (€ 273,832) Favourable step	€ -84,821 Gross margin 2025: € -84,821 ▼ € 1.3 million vs 2024 (€ 1,245,286) Unfavourable step	▼ € 1.3 million
Profit after taxes	€ 124,944 Profit after taxes 2022: € 124,944 First fiscal year in the series	€ 174,187 Profit after taxes 2023: € 174,187 ▲ 39% vs 2022 (€ 124,944) Favourable step	€ 845,297 Profit after taxes 2024: € 845,297 ▲ € 671,111 vs 2023 (€ 174,187) Favourable step	€ -101,559 Profit after taxes 2025: € -101,559 ▼ € 946,856 vs 2024 (€ 845,297) Unfavourable step	▼ € 946,856
Equity	€ 1,882,027 Equity 2022: € 1,882,027 First fiscal year in the series	€ 1,685,185 Equity 2023: € 1,685,185 ▼ 10% vs 2022 (€ 1,882,027) Unfavourable step	€ 2,395,937 Equity 2024: € 2,395,937 ▲ 42% vs 2023 (€ 1,685,185) Favourable step	€ 2,294,378 Equity 2025: € 2,294,378 ▼ 4% vs 2024 (€ 2,395,937) Unfavourable step	▼ 4%
Total debts	€ 11,071 Total debts 2022: € 11,071 First fiscal year in the series	€ 5,005 Total debts 2023: € 5,005 ▼ 55% vs 2022 (€ 11,071) Favourable step	€ 112,841 Total debts 2024: € 112,841 ▲ € 107,835 vs 2023 (€ 5,005) Unfavourable step	€ 3,432 Total debts 2025: € 3,432 ▼ 97% vs 2024 (€ 112,841) Favourable step	▼ 97%
Cash	€ 760,851 Cash 2022: € 760,851 First fiscal year in the series	€ 573,493 Cash 2023: € 573,493 ▼ 25% vs 2022 (€ 760,851) Unfavourable step	€ 301,761 Cash 2024: € 301,761 ▼ 47% vs 2023 (€ 573,493) Unfavourable step	€ 226,788 Cash 2025: € 226,788 ▼ 25% vs 2024 (€ 301,761) Unfavourable step	▼ 25%
Retained profit	€ 1,863,427 Retained profit 2022: € 1,863,427 First fiscal year in the series	€ 1,666,585 Retained profit 2023: € 1,666,585 ▼ 11% vs 2022 (€ 1,863,427) Unfavourable step	€ 2,377,337 Retained profit 2024: € 2,377,337 ▲ 43% vs 2023 (€ 1,666,585) Favourable step	€ 2,275,778 Retained profit 2025: € 2,275,778 ▼ 4% vs 2024 (€ 2,377,337) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 371,029 Dividend 2023: € 371,029 Unchanged (€ 0) Unchanged	€ 134,545 Dividend 2024: € 134,545 ▼ 64% vs 2023 (€ 371,029) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 134,545) Unchanged	▼ 100%
Balance sheet total	€ 1,893,098 Balance sheet total 2022: € 1,893,098 First fiscal year in the series	€ 1,690,190 Balance sheet total 2023: € 1,690,190 ▼ 11% vs 2022 (€ 1,893,098) Unchanged	€ 2,508,778 Balance sheet total 2024: € 2,508,778 ▲ 48% vs 2023 (€ 1,690,190) Unchanged	€ 2,297,810 Balance sheet total 2025: € 2,297,810 ▼ 8% vs 2024 (€ 2,508,778) Unchanged	▼ 8%

Key figures of DR. MARC FOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MARC FOL?

What happened at DR. MARC FOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 12, 2026 New annual accounts for financial year 2025: loss of € 101,559 (▼ € 946,856 vs 2024). filed late Source: NBB ↗
Feb 18, 2003 New establishment in Londerzeel. KBO
Feb 18, 2003 Start of the company according to the CBE. KBO

In short

From € 124,944 profit in 2022 to € 101,559 loss in 2025.

Paid € 523,526 in corporate taxes since 2022.

Best year ever: 2024, with € 845,297 profit.

Paid out € 505,574 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marc Fol

DR. MARC FOL

Behind DR. MARC FOL is Marc Fol.

Directors

According to the 2025 annual accounts

Marc Fol

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Maldersesteenweg 37

1840 Londerzeel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.575.324
VAT number: BE 0479.575.324
Registered office: Maldersesteenweg 37, 1840 Londerzeel
Names & denominations: DR. MARC FOL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 February 2003
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗